Nantahala Capital Management, LLC Eton Pharmaceuticals, Inc. Transaction History
Nantahala Capital Management, LLC
- $1.99 Billion
- Q4 2024
A detailed history of Nantahala Capital Management, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 1,118,483 shares of ETON stock, worth $18.5 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
1,118,483
Previous 998,733
11.99%
Holding current value
$18.5 Million
Previous $5.99 Million
145.46%
% of portfolio
0.74%
Previous 0.36%
Shares
3 transactions
Others Institutions Holding ETON
# of Institutions
72Shares Held
12.2MCall Options Held
259KPut Options Held
500-
Opaleye Management Inc. Boston, MA2.85MShares$47.3 Million7.38% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.83MShares$30.3 Million1.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.06MShares$17.6 Million0.0% of portfolio
-
Westside Investment Management, Inc.575KShares$9.53 Million1.61% of portfolio
-
Mink Brook Asset Management LLC West Palm Beach, FL456KShares$7.55 Million5.81% of portfolio
About Eton Pharmaceuticals, Inc.
- Ticker ETON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,297,000
- Market Cap $419M
- Description
- Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...